Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Spinal Cord Injury
  4. Targeting a Dominant Negative Rho Kinase to Neurons Promotes Axonal Outgrowth and Partial Functional Recovery After Rat Rubrospinal Tract Lesion

Targeting a Dominant Negative Rho Kinase to Neurons Promotes Axonal Outgrowth and Partial Functional Recovery After Rat Rubrospinal Tract Lesion

Molecular Therapy, 2009 · DOI: 10.1038/mt.2009.168 · Published: July 21, 2009

Spinal Cord InjuryNeurologyGenetics

Simple Explanation

The study investigates whether blocking the RhoA-ROCK signal pathway, known to inhibit axon regeneration after CNS injury, can promote axon outgrowth and functional recovery. This was achieved by neuron-specific expression of a dominant negative mutant of ROCK (DNROCK) using lentiviral vectors. In vitro experiments showed that DNROCK-expressing neurons had a greater chance of generating neurites and longer neurites compared to control neurons when seeded on myelin proteins, which are known inhibitors of axon growth. In vivo experiments involved injecting lentiviruses into the red nucleus of adult rats, followed by transection of the rubrospinal tract (RST). The DNROCK group exhibited better functional recovery in both hindlimbs and forelimbs compared to the control group, with more RST axons growing to the spinal cord caudal to the lesion.

Study Duration
10 weeks
Participants
Adult Wister rats
Evidence Level
Not specified

Key Findings

  • 1
    DNROCK expression in DRG neurons promotes neurite growth on myelin proteins in vitro, overcoming the inhibitory effects of CNS myelin.
  • 2
    Inhibition of ROCK by DNROCK reduces myelin-induced phosphorylation of CRMP2 at growth cones, a key mediator of growth cone collapse.
  • 3
    In vivo, DNROCK promotes axonal outgrowth of axotomized RST, leading to more axons growing around and beyond the lesion site.

Research Summary

The study demonstrates that lentiviral delivery of DNROCK to neurons can effectively target the RhoA-ROCK signal pathway, promoting regenerative sprouting of injured axons after CNS injury. DNROCK enhances neurite outgrowth in vitro on inhibitory myelin substrates and, in vivo, promotes growth of severed RST axons into and around the lesion cavity, leading to partial functional recovery. The results suggest that suppressing the RhoA-ROCK signal pathway with DNROCK is a promising strategy for future treatments of CNS injury, although more detailed studies are needed to confirm its effectiveness across different injury models and motor pathways.

Practical Implications

Therapeutic Target

The RhoA-ROCK pathway is validated as a therapeutic target for promoting axonal regeneration after CNS injury.

Gene Therapy Potential

Lentiviral delivery of DNROCK shows promise as a gene therapy approach to enhance axon outgrowth and functional recovery.

Combination Therapies

Combining DNROCK expression with other strategies, such as modifying the glial scar or co-expressing growth-promoting molecules, may further enhance CNS axon regeneration.

Study Limitations

  • 1
    Long-distance regeneration of axons was not observed with ROCK inhibition alone.
  • 2
    Physical and biochemical barriers of the lesion cavity still impede axonal sprouts.
  • 3
    More detailed studies are needed to confirm the effectiveness of this strategy in different injury models and motor pathways.

Your Feedback

Was this summary helpful?

Back to Spinal Cord Injury